BioMed Partners and High-Tech Gründerfonds (HTGF) have co-led a €10.7m round for Germany-based Tubulis, a developer of antibody-drug conjugates (ADC).
Glass Container companies are portfolio companies of Horizon Capital’s Western NIS Enterprise Fund
Seed investor Heartbeat Labs will retain a 10% stake in Fernarzt
Innovery is a portfolio company of Wisequity IV, which closed on €215m and is currently 92% deployed
Fund will be larger than its predecessor, which closed on €280m in July 2018